This activity is intended for physicians, physician assistants, nurse practitioners, registered nurses, and other allied healthcare professionals specializing or certified in the areas of gynecology, obstetrics, internal medicine, family or general medicine.
Goals and Objectives
Despite safe and effective non-pharmacologic and pharmacologic treatment for hypertension, the cardiovascular disease burden attributed to partially or untreated hypertension continues to be a major public health crisis. To address this disease burden in the United States, and now globally, hypertension guidelines have been periodically developed to aid in the clinical diagnosis, management, and treatment of the individual with hypertension. Recently in 2018, the American College of Cardiology and the American Heart Association (ACC-AHA) released new hypertension guidelines. These guidelines differed greatly from previous guidelines in the United States as well as other countries. Given the magnitude of the changes in these guidelines, there is a need to review these guidelines and the evidence-based medicine that led to the changes proposed and to determine the clinical applicability of the guidelines. Since the ACC-AHA Hypertension Guideline release competing guidelines have also been published. Of these guidelines the European Society of Cardiology/European Society of Hypertension 2018 Hypertension Guideline was most recently released. Some of the recommendations in this most recent guideline differ from those previously. Due to the changes given, there is a need to review these guidelines and the evidence-based medicines that lead to the recommendations of each and to determine the clinical applicability of the guidelines. At the conclusion of this activity, participants should be able to:
- Compare and contrast the recommendations of the ACC-AHA 2018 Hypertension Guidelines to those previously published;
- Review the important new clinical studies and their results which led to the changes proposed in the ACC-AHA 2018 guidelines;
- Review the recommendations of the recently published ESC/ESH 2018 Hypertension Guideline;
- Determine the clinical importance and applicability of the ACC-AHA 2018 Hypertension Guidelines to the practicing clinician in the management and treatment of hypertension.
CME Release Date: August 2, 2019
Valid for credit through: August 2, 2020
Course type: Video lecture
Southern Medical Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA PRA Category 1 Credits™
Southern Medical Association designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board. All healthcare professionals who are not MDs or DOs will receive a certificate of participation.
Instructions for Participation and Credit
To successfully earn credit, participants must complete the activity online during the valid credit period noted, following these steps:
- Read the goals and objectives, accreditation information, and author disclosures.
- View the educational video of the lecture.
- Study the educational references.
- Online, choose the best answer to each test question. Learners must receive a passing score of 80%.
- Complete the activity evaluation and outcomes.
Upon successful completion of the test, evaluation and attestation, your certificate will be processed and emailed from [email protected] within approximately 1 hour. Credits will be archived for 6 years; at any point within this time period you may login to your account to print a duplicate copy of your certificate.
Click the Disclosure Tab above for Faculty Information
Disclosure of Relevant Financial Relationships
As an organization accredited by the ACCME, Southern Medical Association requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest.
Southern Medical Association encourages Speakers/Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Donald J. DiPette, MD, FACP, FAHA
Dr. DiPette is currently the Health Sciences Distinguished Professor at the University of South Carolina and the University of South Carolina School of Medicine in Columbia, South Carolina. He has previously held the positions of Special Assistant to the Provost for Health Affairs, Vice President for Medical Affairs and Dean of the School of Medicine at the University of South Carolina. Before joining USC, he was Interim Senior Executive Dean and Interim Chief Academic Officer and Professor of Medicine in the Texas A&M Health Sciences Center College of Medicine and the Chairman of the Department of Medicine at Texas A&M Health Sciences Center College of Medicine and Scott & White Healthcare.
- The speaker has no relevant financial relationships to disclose.
Planning Committee/Content Reviewer(s)/SMA Staff:
The following planning committee members have no relevant financial relationships to disclose:
Veronica K. Piziak, MD
Nancy Phillips, MD
Susan Peck, MSN, APN
Lee Boughton, MA, SMA Staff
This content is limited to qualifying members.
If you have an existing account please login now to access this article or view your purchase options.
Create a free account, then purchase purchase access to this course.